DOI QR코드

DOI QR Code

Solubility Enhancement and Antibacterial Activity of Chloramphenicol Includedin Modified β-Cyclodextrins

  • Zuorro, Antonio (Department of Chemical Engineering, "La Sapienza" University) ;
  • Fidaleo, Marco (Department of Cellular and Developmental Biology, "La Sapienza" University) ;
  • Lavecchia, Roberto (Department of Chemical Engineering, "La Sapienza" University)
  • Received : 2010.06.07
  • Accepted : 2010.09.15
  • Published : 2010.11.20

Abstract

Keywords

References

  1. Wareham, D. W.; Wilson, P. J. Hosp. Med. 2002, 63, 157-161. https://doi.org/10.12968/hosp.2002.63.3.2061
  2. Balbi, H. J. Pediatr. Rev. 2004, 25, 284-288. https://doi.org/10.1542/pir.25-8-284
  3. Fukuda, M.; Ohashi. H.; Matsumoto, S.; Mishima, S.; Shimomura, Y. Cornea 2002, 21, S86-S89 https://doi.org/10.1097/01.ico.0000263125.99262.42
  4. Lam, R. F.; Lai, J. S. M.; Ng, J. S. K.; Rao, S. K.; Law, R. W. K.; Lam, D. S. C. Hong Kong Med. J. 2002, 8, 44-47.
  5. Elton, M. Pharm. J. 2005, 274, 725-728.
  6. Drainas, D.; Kalpaxis, D.; Coutsogeorgopoulos, C. Eur. J. Biochem. 1987, 164, 53-58. https://doi.org/10.1111/j.1432-1033.1987.tb10991.x
  7. Ghate, D.; Edelhauser, H. F. Expert Opin. Drug Deliv. 2006, 3, 275-287. https://doi.org/10.1517/17425247.3.2.275
  8. Stella, V. J.; Nti-Addae, K. W. Adv. Drug Deliv. Rev. 2007, 59, 677-694. https://doi.org/10.1016/j.addr.2007.05.013
  9. Brewster, M. E.; Loftsson, M. Adv. Drug. Deliv. Rev. 2007, 59, 645-666. https://doi.org/10.1016/j.addr.2007.05.012
  10. Arun, R.; Ashok Kumar, C. K.; Sravanthi, V. V. N. S. S. Sci. Pharm. 2008, 76, 567-598. https://doi.org/10.3797/scipharm.0808-05
  11. Chernykh, E. V.; Brichkin, S. B. High Energy Chem. 2010, 44, 83-100. https://doi.org/10.1134/S0018143910020013
  12. Loftssona, T.; Jarvinen, T. Adv. Drug. Deliv. Rev. 1999, 36, 59-79. https://doi.org/10.1016/S0169-409X(98)00055-6
  13. Le Bourlais, C.; Acar, L.; Zia, H.; Sado, P. A.; Needham, T.; Leverge, R. Prog. Retin. Eye Res. 1998, 1, 33-58.
  14. Stefansson, E.; Loftsson, T. J. Incl. Phenom. Macroc. Chem. 2002, 44, 23-27. https://doi.org/10.1023/A:1023015201493
  15. Zhang, J.; Wang, L.; Gao, C.; Zhang, L.; Xia, H. J. Ocul. Parmacol. Ther. 2008, 24, 501-506. https://doi.org/10.1089/jop.2008.0015
  16. Valls, R.; Vega, E.; Garcia, M. L.; Egea, M. A.; Valls, J. O. Open Med. Chem. J. 2008, 2, 66-71. https://doi.org/10.2174/1874104500802010066
  17. Majumdar S.; Srirangam, R. Pharm. Res. 2009, 26, 1217-1225. https://doi.org/10.1007/s11095-008-9729-6
  18. Higuchi, T.; Connors, K. A. Adv. Anal. Chem. Instr. 1965, 4, 117-212.
  19. Chen, M.; Diao, G.; Zhang, E. Chemosphere 2006, 63, 522-529. https://doi.org/10.1016/j.chemosphere.2005.08.033
  20. Alfonso, E.; Crider, J. Surv. Ophthalmol. 2005, 50, S1-S6. https://doi.org/10.1016/j.survophthal.2005.05.001
  21. Kowalski, R. P.; Dhaliwal, D. K. Expert Rev. Anti Infect. Ther. 2005, 3, 131-139. https://doi.org/10.1586/14787210.3.1.131
  22. Woodward, M.; Randleman, J. B. J. Cataract. Refract. Surg. 2007, 33, 213-219.
  23. Sotozono, C.; Inagaki, K.; Fujita, A.; Koizumi, N.; Sano, Y.; Inatomi, T.; Kinoshita, S. Cornea 2002, 21, S94-S101. https://doi.org/10.1097/01.ico.0000263127.84015.3f
  24. Bourcier, T.; Thomas, F.; Borderie, V.; Chaumeil, C.; Laroche, L. Br. J. Ophthalmol. 2003, 87, 834-838. https://doi.org/10.1136/bjo.87.7.834
  25. Vuong, C.; Otto, M. Microbes Infect. 2002, 4, 481-489. https://doi.org/10.1016/S1286-4579(02)01563-0

Cited by

  1. Enhanced antibacterial and anti-quorum sensing activities of triclosan by complexation with modified β-cyclodextrins vol.29, pp.9, 2013, https://doi.org/10.1007/s11274-013-1335-z
  2. Preparation of Chloramphenicol/Amino Acid Combinations Exhibiting Enhanced Dissolution Rates and Reduced Drug-Induced Oxidative Stress vol.18, pp.8, 2017, https://doi.org/10.1208/s12249-017-0775-4
  3. The mode of antimicrobial action of curcumin depends on the delivery system: monolithic nanoparticles vs. supramolecular inclusion complex vol.7, pp.67, 2017, https://doi.org/10.1039/C7RA07303H
  4. Inclusion interaction of chloramphenicol and heptakis (2,6-di-O-methyl)-β-cyclodextrin: Phase solubility and spectroscopic methods vol.83, pp.1, 2011, https://doi.org/10.1016/j.saa.2011.09.005
  5. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac vol.16, pp.6, 2010, https://doi.org/10.1080/17425247.2019.1609447
  6. Fabrication of large pore mesoporous silica microspheres by salt-assisted spray-drying method for enhanced antibacterial activity and pancreatic cancer treatment vol.590, pp.None, 2010, https://doi.org/10.1016/j.ijpharm.2020.119930
  7. Chloramphenicol Loaded Sponges Based on PVA/Nanocellulose Nanocomposites for Topical Wound Delivery vol.5, pp.8, 2010, https://doi.org/10.3390/jcs5080208